Abstract: Phencyclidine (I) and its derivatives show such pharmacological behaviors as analgesic, anticonsulvant, anti-anxiety and antidepressant, while interacting with central nervous system. In this study, new methyl and hydroxyl derivatives of PCP were synthesized and their antinociceptive behaviors in animals were examined by measuring the number of writhing in a writhing test of visceral pain and the pain scores in Formalin test. Compared to control and PCP groups, findings in experimental groups indicated the new synthesized analogues (compounds II, III and V, 10 mg/kg) of PCP were able to produce more analgesic effects in formalin and writhing tests, especially for compound V. It was concluded that the new synthesized derivatives of PCP could substantially and respectively diminish acute and chronic pains.
INTRODUCTION
Phencyclidine (1-[1-phenylcyclohexyl] piperidine, PCP, I, Scheme 1) is an aryl cyclohexyl amine compound that has received much investigative attention due to the complex spectrum of behaviors it induces and its complicated interaction with the central nervous system (CNS). Phencyclidine administration may mimic pharmacological properties similar to those of stimulants, depressants, hallucinogens and analgesic agents depending upon the dosage and species tested [1] . Also, experimental evidence suggests that glutamate receptors are involved in the mechanisms controlling the acquisition and expression of pain-related behaviors [2] . Majority of the PCP effects occurs in the central nervous system, at least at recreational doses. Effects on other organ systems seem to be significant only in overdose situations. It hardly appears to be a specific PCP receptor in human brain as PCP seems to bind to the N-methyl-D-aspartate (NMDA) receptor [3, 4] . Phencyclidine analogues also bind to this site, while the binding efficiency tends to correlate with the potency of the analog [5] . Glutamate is the major excitatory neurotransmitter in the CNS involved in many physiological and pathophysiological situations, including spinal and supraspinal pain transmission. Therefore, the glutamate receptor antagonists, particularly the NMDA receptor antagonists, are amongst important agents in controlling various types of pain [6] . Recently, several PCP derivatives (with substitution changes in the molecule) have been synthesized and their pharmacological activities have been tested [7] [8] [9] [10] [11] [12] [13] . Revealed in the previous works [8-10, 12, 13] on this family of compounds, the incorporation of methyl group to the aromatic ring of the molecule generates pronounced effects on electron distribution and dipole moments because of its high electron donating character [14] . In addition, the hydroxyl group with high hydrophilic, polarity, and solubility properties [15] may produce more analgesic effects on this family. In this study, to produce the pronounced analgesic effects, phencyclidine (I), 2-phenyl-2-piperidine-1-yl-cyclohexanol (IV) and some of their new analogues (3-Methyl-4-(1-piperidin-1-ylcyclohexyl)-phenol (II), 1-[1-(4-Hydroxy-2-methyl-phenyl)-cyclohexyl]-piperidin-4-ol (III) and 1-(2-hydroxy-1-p-tolyl-cyclohexyl)-piperidine-4-ol (V)), were synthesized. Their antinociception behaviors in animals were determined by counting the number of writhing in writhing tests and measuring the pain scores in formalin test. 
, and 1-(2-hydroxy-1-p-tolyl-cyclohexyl)-piperidine-4-ol (V).
MATERIALS AND METHOD

General
In this study, cyclohexanone, piperidine, bromo benzene, magnesium turning, diethyl ether, 4-hydroxy piperidine, 4-chloro-3-methyl phenol, N-bromoacetamide (NBA), potassium t-butoxide and all other chemicals were purchased from Merck Chemical Co. (Darmstadt, Germany). Melting points (uncorrected) were determined with a digital electrothermal melting point apparatus (model 9100, Electrothermal Engineering Ltd., Essex, UK).
1 H and 13 C NMR spectra were recorded by Bruker 300 MHz (model AMX, Karlsruhe, Germany) spectrometer (internal reference: TMS). IR spectra were recorded by a Thermo Nicolet FT-IR (model Nexus- The compounds were prepared in an organic solvent based on a published method from piperidine to 4-piperidinol, cyclohexanone and KCN [16] .
1-[1-phenylcyclohexyl] Piperidine (PCP) (I)
This compound was prepared based on a published method from a solution of 1-piperidinocyclohexanecarbonitrile (1) in an organic solvent to a refluxing solution of phenyl magnesium bromide (prepared from 79g bromobenzene and 12.3g Mg in 200 ml of dry ether). The hydrochloride salt of I (m.p. 233-234˚ C) was prepared with 2-propanol and HCl, before it was recrystallized from 2-propanol [17] .
1-[1-[3-hydroxy-5-methylphenyl] [cyclohexyl] piperidine (II)
A solution, containing 3.9g (0.023mol) of nitrile compound (1) in the mixture of dry diethyl ether and toluene (1:1) was added to a refluxing solution of 4-hydroxy-2-methyl phenyl magnesium chloride (Grignard reagent) which was prepared from 7.35g of 4-chloro-3-methyl phenol and 1.23g Mg in 60ml dry ether. It was refluxed for 14 additional days and left overnight at ambient temperature (25˚C) before it was poured into ice-NH 4 Cl. The organic layer was separated and the aqueous layer extracted with diethyl ether. The combined organic layers water-washed, reextracted with 10% H 2 SO 4 , neutralized with 10% NaOH and reextracted with n-Hexane. The organic layer was successively waterwashed, dried over MgSO 4 and evaporated under vacuum to obtain an oily compound (II, 3.1 g, 56% yield). The hydrochloride salt of II (m.p. 174-175˚C) was prepared with diethyl ether and HCl. It was recrystallized from 2-propanol. 
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1-[1-[3-hydroxy-5-methylphenyl] [cyclohexyl]-4-piperidinol (III)
A solution, containing 4.16 g (0.023mol) of nitrile compound (2) in the mixture of dry diethyl ether and toluene (1:1) was added to a refluxing solution of 4-hydroxy-2-methylphenyl magnesium chloride (Grignard reagent) which was prepared from 7.35 g of 4-chloro-3-methyl phenol and 1.23g Mg in 100ml dry ether. It was refluxed for 20 additional days and left overnight at ambient temperature (25˚C) before it was poured into ice-NH 4 Cl. The organic layer was separated and the aqueous layer extracted with diethyl ether. The combined organic layers washed with water, reextracted with 10% H 2 SO 4 , neutralized with 10% NaOH and reextracted with n-Hexane. The organic layer was successively waterwashed, dried over MgSO 4 and evaporated under vacuum to obtain an oily compound (III, 2.82 g, 49% yield). The hydrochloride salt of III (m.p. 177-178˚ C) was prepared with diethyl ether and HCl, It was recrystallized from 2-propanol. 
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1-phenylcyclohexanol (3) and 1-(p-tolyl) cyclohexanol (5)
These compounds were prepared from phenyl magnesium bromide or p-tolyl magnesium bromide and cyclohexanone based on published methods [18, 19] .
1-phenylcyclohexene (4) and 1-(p-tolyl) cyclohexene (6)
Compounds were prepared from compounds 3 or 5 and mixture of sulfuric and glacial acetic acid, based on a published method [18, 19] .
2-Bromo-1-phenyl-cyclohexanol (7) and 2-Bromo-1-p-tolylcyclohexanol (9)
Compounds were prepared from addition of 0.0247mol of 4 or 6 in 70%dioxane (120ml) to 3.65g (0.0265mol) NBA in 50%dioxane, warmed in hot water for 2 minutes. Next, the mixture was poured into ice-water, extracted with ether, dried and concentrated. The concentrated oil compounds (4g and 4.1g) were obtained (59% and 56%yields). Potassium t-butoxide (2.2g, 0.0196mol) was added to the solutions of 7 or 9 in benzene (120ml) and stirred for one hour. Then Potassium t-butoxide (2.2g, 0.0196mol) was re-added and stirred for 3 more hours. Then water was added, extracted with benzene, dried and concentrated. The concentrated oil compounds (1.5 and 1 g) were obtained (68% and 56% yields).
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2-phenyl-2-piperidine-1-yl-cyclohexanol (IV)
The compound was prepared based on a published method with some modifications [20, 21] . Compound 8 (2.26 g, 0.013 mol), ethylene glycol (50 ml) and piperidine (11.9 g, 0.14 mol) were refluxed for 16 hours. The mixture was poured into ice-water and extracted by ether. The organic layer was separated and the aqueous layer extracted with diethyl ether. The combined organic layers water-washed, re-extracted with 10% H 2 SO 4 , neutralized with 10% NaOH and re-extracted with diethyl ether. The organic layer was successively water-washed, dried over MgSO 4 and evaporated under vacuum to obtain an oily compound (mixture of two isomers) which was passed from silica gel column chromatography to afford white solid compound (IV, 2 g, 54% yield) (m.p. 135 ˚C ).
1-(2-hydroxy-1-p-tolyl-cyclohexyl)-piperidine-4-ol (V)
A mixture of 2.444g (0.014mol) of 10 and 14.4g (0.14mol) 4-piperidinol in ethylene glycol (50ml) was refluxed for 16 hours. It was poured into ice-water and extracted by ether. The organic layer was separated and the aqueous layer extracted with diethyl ether. The combined organic layers water-washed, re-extracted with 10% H 2 SO 4 , neutralized with 10% NaOH and re-extracted with diethyl ether. The organic layer was successively water-washed, dried over MgSO 4 and evaporated under vacuum to obtain the oily compound (mixture of two isomers) which was passed from silica gel column chromatography to afford 1.9 g (50% yield) of V. 
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Pharmacological Methods
Subjects
Fifty-eight adult male Wistar rats (250-300g) and male NMRI mice (25-30g) (Pasteur's Institute, Tehran) were experimented with Formalin and Writhing tests, respectively. Animals were kept under standard laboratory conditions, with tap water and regular rat chow ad libitum. They were housed in groups of five animals in each cage in a temperature (22±2˚C) and humidity controlled room on 12 hours light/dark cycles. All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institute of Health Publication No. 80-23, revised 1996) and were approved by the Research and Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran-Iran.
Behavioral studies
Formalin-Induced Nociceptive Behavior
Formalin test was carried out to evaluate the antinociceptive effects of PCP and its new derivatives against inflammatory pain [22] . Fifty-eight male Wistar albino rats, weighing 250 to 300g, were placed individually in an open Plexiglas chamber (35 35 35cm 3 ) with a mirror angled at 45º below position to allow an unobstructed view of the paws by the researchers. The animals were habituated to the observation chamber for 30 minutes prior to the experimental sessions. Formalin solutions were prepared at 2.5% in saline from a formalin stock (Sigma, St. Louis, USA) and injected intradermally (i.d.) to right hind paw of rat in a volume of 50 l with a 27-gauge needle (the formalin stock corresponds to a 37% formaldehyde solution). Observations to determine nociceptive responses began upon placing the rats into the box and continued for the following 60 minutes. A nociceptive score was determined for every 5-minute block by measuring the amount of time spent in every four behavioral categories (0=the position and posture of the injected hind paw was indistinguishable from the contra lateral paw; 1=the injected paw had little or no weight placed on it; 2=the injected paw was elevated with no contact with any surface; 3=the injected paw was licked, bitten or shaken). Then, a weighted nociceptive score, ranging from 0 to 3, was calculated by multiplying the time spent in every category by the category weight, summed and divided by the total time spent (300seconds) for every 5-minute block. Separate groups of rats (n=7-8 rats per group) received various derivatives of Phencyclidine (10mg/kg) or saline, 30 min prior to formalin injection.
Acetic Acid-Induced writhing in Mice
Visceral chemical antinociception was evaluated with Writhing test [23] . Separate groups of mice (9-10 mice per group) were pretreated with phencyclidine and its various derivatives and i.p. injection of the compounds. Thirty minutes later, acetic acid (0.6% v/v, 10 mg/kg) was i.p. injected before the mice were placed in an observation box. The intensity of nociceptive behaviors was quantified by counting the total number of writhes between 0 and 30 min after acid acetic injection. The writhing responses consisted of contraction of the abdominal muscles.
Statistical Analysis
Nociception in animals was determined by counting the number of writhings in Writhing test and the pain scores in Formalin test. In Formalin test, the overall change sin pain score were evaluated by obtaining the area-under-the-curve (AUC) of pain scores. To compare the pain scores changes in control and treated rats in Formalin test, a two-way analysis of variance (ANOVA) was conducted. For comparing AUCs of pain scores in Formalin test and fluctuation in the number of writhing in Writhing test, one-way ANOVA followed by Tukey's test of multiple comparisons were applied. Statistical analysis was performed using Graph Pad Prism 5 (Graph Pad Software Inc.) under the level of p<0.05 statistical significance.
RESULTS
Chemistry
Phencyclidine (I), 2-phenyl-2-piperidine-1-yl-cyclohexanol (IV) and some of their new analogues (3-methyl-4-(1-piperidin-1-yl-cyclohexyl)-phenol (II), 1-[1-(4-hydroxy-2-methyl-phenyl)-cyclohexyl]-piperidin-4-ol (III) and 1-(2-hydroxy-1-p-tolylcyclohexyl)-piperidine-4-ol (V)) were synthesized by the reaction of substituted Grignard reagent with carbonitrile compounds, or by addition of NBA to arylalkenes to produce aryl bromohydrin cyclohexanes compounds and potassium t-butoxide to produce aryl-1,2-epoxycyclohexanes [24] . Addition of piperidine or 4-piperidinol to the phenyl or p-tolyl-1,2-epoxycyclohexanes (8 and 10) yielded the desired compounds (IV and V) [16] [17] [18] [19] [20] [21] .
Demonstrated in literature on this family of compounds [8-10, 12, 13] , the incorporation of methyl group to the aromatic ring of the molecule generates some pronounced effects on electron distribution and dipole moments due to its high electron donating character [14] . In addition, the hydroxyl group with high hydrophilic, polarity, and solubility properties [15] produces more analgesic effects on this family [8, 10, 13] . Therefore, as it was anticipated, compounds II, III, and V showed more antinociception effects, relative to control and phencyclidine groups. Spectroscopic data (IR, 1 H and 13 C NMR, Mass) confirmed the structure of the compounds 7-10, II, III and V. The melting points of the known compounds also confirmed their identity. The purity of every compound was checked by TLC with ethyl acetate-hexane as the eluent.
Pharmacology
General Consideration
Mortality (number of death), morbidity (abnormal condition or behavior due to a disorder), irritability (aggressiveness or increased response on handling) and other related abnormal states were not observed in the experimental animals. However, the motor coordination index (measured by Rota-rod apparatus, Harvard, UK) did not indicate any significant differences among the treated rats or mice (data not shown).
Effect of Phencyclidine and its Derivatives on Pain Related Behavior of Rats in Formalin Test
Intradermal injection of formalin into dorsal surface of hind paw produced a biphasic pain related behavior in rats (Fig. 1) . Twoway ANOVA revealed a significant effects of treatment for V [F (1,144) =53.45, p<0.0001; Fig. 1B], II [F(1,144) =8.788, p=0.0118; Fig. 1C] , and III [F(1,144)=23.37, p=0.0004; Fig. 1E] . Moreover, one-way ANOVA revealed a significant difference in the AUC of pain scores for various compounds [F (5,42) = 8.445, p<0.0001; Fig. 2 ]. Further analysis with Tukey's multiple comparison test, revealed a significant decrease in AUC of pain scores in rats treated with V (p<0.001), II (p<0.05), and III (p<0.001) compared to control group. No significant variations in AUC of pain score were observed in rats pretreated with drug no.4 (I) (phencyclidine) compared to control group (Fig. 2) . In addition, V also showed significant decrease in AUC of pain scores compared to I in pretreated group (p<0.01). Fig. (2) . Changes in the AUC of pain scores in Formalin test. Rats were pretreated with vehicle (control group), phencyclidine (I, 10 mg/kg), or phencyclidine derivatives (II-V; 10 mg/kg) 30 min before Formalin test. Bars represent mean+S.E.M of 7-8 rats. * p<0.05, ** p<0.01, *** p<0.001 significant difference compared to control group. ++ p<0.01, significant differences compared to phencyclidine (I) treated group. 
Effect of Phencyclidine and its Derivatives on Pain Related Behavior of Rats in Writhing Test
As shown in Fig. (3) , One-way ANOVA revealed a significant change in the number of writhings for experimental groups [F(6,49)=12.19, p<0.0001]. Further analysis with Dunnett's multiple comparison test revealed a significant decrease in number of writhings for the mice pretreated with IV (P<0.01), V (p<0.001), II (p<0.001), and III (p<0.01) compared to the control group. No significant change in the number of writhing was observed in rats pretreated with drug no. 4 (I) (phencyclidine), with the same dosage of the other compounds (Fig. 3) . Fig. (3) . Compared number of writhings after i.p. administration of acetic acid in mice in experimental groups. Animals in every group was pretreated with vehicle (control group), phencyclidine (I, 10 mg/kg), or phencyclidine derivatives (II-V; 10 mg/kg) 30 min before writhing test. Bars represent mean+S.E.M. of 9-10 mice. ** p<0.01, *** p<0.001 significant difference compared to control group. + p<0.05, ++ p<0.01, +++ p<0.001 significant differences compared to phencyclidine (I) treated group.
DISCUSSION
Phencyclidine was originally developed to be used in humans as an anesthetic in 1959, but soon it was restricted due its psychotomimetic effects which included prolonged thoughts and visual disturbances and agitation [25] . Consequently, the focus of research on PCP shifted from its application as an anesthetic compound toward potential application as a neuropharmaceuticals [26] . Furthermore, the search on noncompetitive NMDA antagonists was substantially assisted through the development of a reliable binding assay. To date, a considerable number of PCP derivatives has been synthesized and assayed as substrates for the PCP binding site [27, 28] .
The analgesic activities of new synthesized analogues of PCP with the changes in substitution on its phenyl and piperidine (with methyl and hydroxyl groups) are determined by counting the number of writhings in Writhing test and the pain scores in Formalin test where the results were compared to control and PCP groups in this study.
As anticipated, the findings indicated that, all of our new synthesized analogues (II, III and V) of I, produced more analgesic effects in Formalin and Writhing tests compared to control and PCP groups, especially for compound V because of methyl group on phenyl and more hydroxyl groups on piperidine and cyclohexane rings that produced a new drug with high electron donating, lipophilic and hydrophilic properties.
It seems because of high electron distribution and dipole moments of methyl group [14] , also high hydrophilic, polarity, and solubility properties of hydroxyl group [15] on aromatic and nonaromatic rings of I, these new drugs (II, III and V) have a noticeable lipophilic-hydrophilic ratio which helps to produce more analgesic effects, compared to control and PCP groups especially for compound V. In comparison, it seems incorporation of hydrophilic group (OH) on cyclohexane ring of I (compound IV) alone is an inefficient factor in producing better pain relief properties. Adding this group to piperidine and phenyl rings in addition of methyl group on aromatic moiety (compound III), similar to compound II (with only these groups in phenyl ring together), could produce more analgesic effects compare to compound IV. Also for compound V, a strong position of the groups (methyl group on aromatic ring with good lipophilic effects and two hydroxyl groups on every cyclohexane and piperidine rings) was traced with no steric hindrance, which could cause to producing a new drug with an excellent receptor antagonistic property for decreasing pain.
In addition, because it was reported that NMDA receptors, especially NR2B-containing receptor subtypes, had a key role in reliving pain [29, 30] , it demonstrated a central mechanism(s) for the mentioned effects via antagonizing the NMDA receptors on pain modulatory center periaqueductal gray. Therefore it was concluded the newly synthetic drugs (compounds II, III and V) could yield more antinociception effects and they could act through central and peripheral analgesic mechanism(s), respectively.
CONCLUSION
It was concluded that these new synthesized derivatives (II, III and V) of PCP, produced more analgesic effects in Formalin and Writhing tests compared to control and phencyclidine groups, especially for compound V with higher electron donating, lipophilic and hydrophilic properties which could substantially and respectively diminish inflammatory and visceral pains.
